{"filing":{"accession_number":"0001104659-26-109304","cik":"0001235912","ticker":"CVRX","company_name":"CVRx, Inc.","form":"8-K","filing_date":"2026-09-21","report_date":"2026-09-16","primary_document":"tm2625806d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1235912/000110465926109304/tm2625806d1_8k.htm"},"events":[{"id":33989,"run_id":31290,"accession_number":"0001104659-26-109304","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of John Landry as Chief Financial Officer of CVRx, effective October 12, 2026, with assumption of CFO duties after the Q3 10-Q filing. While the filing also references the prior resignation of Jared Oasheim (disclosed June 8, 2026), the principal action announced on September 21, 2026 is Landry's appointment. The disclosure includes detailed compensation arrangements (base salary $500,000, 50% target bonus, equity awards of 0.80% of shares outstanding, and severance terms), which are material to investors assessing executive leadership continuity and capital allocation.","company_name":"CVRx, Inc.","ticker":"CVRX","filing_date":"2026-09-21","form":"8-K","submitted_at":null,"items":[{"id":37598,"accession_number":"0001104659-26-109304","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of John Landry as Chief Financial Officer of CVRx, effective October 12, 2026, with assumption of CFO duties after the Q3 10-Q filing. While the filing also references the prior resignation of Jared Oasheim (disclosed June 8, 2026), the principal action announced on September 21, 2026 is Landry's appointment. The disclosure includes detailed compensation arrangements (base salary $500,000, 50% target bonus, equity awards of 0.80% of shares outstanding, and severance terms), which are material to investors assessing executive leadership continuity and capital allocation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T20:14:47.177830+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37598,"accession_number":"0001104659-26-109304","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of John Landry as Chief Financial Officer of CVRx, effective October 12, 2026, with assumption of CFO duties after the Q3 10-Q filing. While the filing also references the prior resignation of Jared Oasheim (disclosed June 8, 2026), the principal action announced on September 21, 2026 is Landry's appointment. The disclosure includes detailed compensation arrangements (base salary $500,000, 50% target bonus, equity awards of 0.80% of shares outstanding, and severance terms), which are material to investors assessing executive leadership continuity and capital allocation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T20:14:47.177830+00:00","company_name":"CVRx, Inc.","ticker":"CVRX","filing_date":"2026-09-21"}]}